The CMTA-STAR Alliance brings together a global network of biotech, pharmaceutical, and research organizations advancing treatment development for Charcot-Marie-Tooth disease (CMT). With 50+ partners across 10 countries, this collaborative ecosystem drives patient-focused research forward.
The map highlights the reach of the CMTA-STAR Alliance, showing just some of the many partners, researchers, and institutions working together around the world to move CMT science forward.
Through the CMTA-STAR Alliance, partners work with CMTA-funded experts and advisors to access specialized CMT models, receive strategic and scientific support, and engage with both key opinion leaders and the CMT community. These shared efforts accelerate the development and delivery of therapies for people living with CMT.
The CMTA-STAR Alliance Partnerships are building momentum, breaking down barriers, and bringing the science to the clinic.
